Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson’s disease genes
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Jiayang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Huffington Foundation, National Institutes of Health.
Abstract (Originalsprache)
Genome-wide association studies (GWAS) have markedly advanced our understanding of the genetics of Parkinson’s disease (PD), but they currently do not account for the full heritability of PD. In many cases it is difficult to unambiguously identify a specific gene within each locus because GWAS does not provide functional information on the identified candidate loci. Here we present an integrative approach that combines transcriptome-wide association study (TWAS) with high-throughput neuronal dysfunction analyses in Drosophila to discover and validate candidate PD genes. We identified 160 candidate genes whose misexpression is associated with PD risk via TWAS. Candidates were validated using orthogonal in silico methods and found to be functionally related to PD-associated pathways (i.e. endolysosome). We then mimicked these TWAS-predicted transcriptomic alterations in a Drosophila PD model and discovered that 50 candidates can modulate α-Synuclein(α-Syn)-induced neurodegeneration, allowing us to nominate new genes in previously known PD loci. We also uncovered additional novel PD candidate genes within GWAS suggestive loci (e.g. TTC19, ADORA2B, LZTS3, NRBP1, HN1L), which are also supported by clinical and functional evidence. These findings deepen our understanding of PD, and support applying our integrative approach to other complex trait disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX, USA.
- Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA.
- Center for Alzheimer's and Neurodegenerative Diseases, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Jiayang Li, Juan Botas
Förderung
- NIA NIH HHS
- Huffington Foundation
- National Institutes of Health
Zitieren
APA
Li, J., Amoh, B. K., McCormick, E., Tarkunde, A., Zhu, K. F., Perez, A., Mair, M., Moore, J., Shulman, J. M., Al-Ramahi, I., & Botas, J. (2023). Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson’s disease genes. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac230
Vancouver
Li J, Amoh BK, McCormick E, Tarkunde A, Zhu KF, Perez A, et al. Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson’s disease genes. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac230
BibTeX
@article{Li2023,
author = {Li, Jiayang and Amoh, Bismark Kojo and McCormick, Emma and Tarkunde, Akash and Zhu, Katy Fan and Perez, Alma and Mair, Megan and Moore, Justin and Shulman, Joshua M and Al-Ramahi, Ismael and Botas, Juan},
title = {Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson’s disease genes},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac230}
}
EUVIMED